We are pleased to announce that the latest issue of Pharmaceutical Industry World (1/2026) features an article authored by our experts, Dr. Joanna Uchańska, Attorney-at-Law, and Edyta Oleszczuk-Romańska, Attorney-at-Law, entitled “AI in Life Science Marketing – Innovations and Risks: How to Combine Them.”
The rapid development of generative artificial intelligence is significantly transforming marketing practices, including within the life sciences sector. Process automation, personalized communication, and rapid content generation are just some of the benefits enabled by AI. At the same time, as the authors point out, implementing AI in highly regulated industries such as pharmaceuticals and dietary supplements involves a number of significant legal and compliance challenges.
The publication discusses, among other things:
- authorship and intellectual property rights issues in relation to AI-generated content;
- challenges associated with the transfer of copyright;
- the risk of plagiarism and the so-called “black box” problem;
- the importance of appropriate contractual and policy provisions;
- limitations arising from AI tools’ Terms of Service;
- regulatory risks in marketing communications; and
- upcoming obligations under the AI Act.
The article also highlights practical measures that businesses should begin implementing now.
We encourage you to explore the full issue of the magazine. If you have any questions regarding the safe implementation of AI within your organization, or if you require assistance in adapting your documentation (including contracts, terms and conditions, and internal policies), please do not hesitate to contact our team.
Enjoy the read!